Wolf-Julian Neumann

Wolf-Julian Neumann is Head of AI Innovation and Therapeutic Neurotechnology at the Wyss Center for Bio and Neuroengineering. His work focuses on the development of AI-driven neurotechnologies that translate brain signals into actionable clinical insights and therapeutic interventions. At the Wyss Center, he is leading the integration of AI with clinical neuroengineering to enable scalable, personalized treatments for neurological and psychiatric disorders.

Prior to joining the Wyss Center, he held a professorship for Invasive Neurotechnology at Charité – Universitätsmedizin Berlin, where he developed and applied implantable neurotechnologies and brain signal decoding approaches in close collaboration with neurology, neurosurgery, and neuroradiology. His work spans the full translational spectrum, from first-in-human studies to clinically deployable systems, with a particular emphasis on reducing barriers to real-world adoption.

He trained and conducted research internationally, including at University College London and University of Pittsburgh Medical Center. With over 15 years of experience in translating neuroscience into clinical innovation, he has contributed to multiple interdisciplinary initiatives and leadership bodies, including the executive board of the Einstein Center for Neurosciences, the board of the Medical Neuroscience Program in Berlin, and the steering committee of ReTune, a multiinstitutional research center for deep brain stimulation.